Skip to content
10-K

Annual Report

Anika Therapeutics, Inc. ANIK

0001171843-26-001275

← back to feed
Filed
Mar 3, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 13.4M sh
Shares Diluted FY 2025 · Dec 31, 2025 14.34M sh
Shares Diluted FY 2025 · Dec 31, 2024 14.72M sh
Shares Diluted FY 2025 · Dec 31, 2023 14.66M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $9.49M
Stock Repurchased FY 2025 · Dec 31, 2024 $10.91M
Stock Repurchased FY 2025 · Dec 31, 2023 $5M
Capex FY 2025 · Dec 31, 2025 $6.83M
Capex FY 2025 · Dec 31, 2024 $7.73M
Capex FY 2025 · Dec 31, 2023 $5.43M
Operating Cash Flow FY 2025 · Dec 31, 2025 $11.19M
Operating Cash Flow FY 2025 · Dec 31, 2024 $5.4M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$1.79M
Cash And Equivalents FY 2025 · Dec 31, 2025 $57.48M
Cash And Equivalents FY 2025 · Dec 31, 2024 $55.63M
Stockholders Equity FY 2025 · Dec 31, 2025 $143.47M
Stockholders Equity FY 2025 · Dec 31, 2024 $153.99M
Stockholders Equity FY 2025 · Dec 31, 2023 $212.27M
Stockholders Equity FY 2025 · Dec 31, 2022 $285.56M
Current Liabilities FY 2025 · Dec 31, 2025 $21.91M
Current Liabilities FY 2025 · Dec 31, 2024 $23.31M
Current Assets FY 2025 · Dec 31, 2025 $103.36M
Current Assets FY 2025 · Dec 31, 2024 $113.65M
Total Assets FY 2025 · Dec 31, 2025 $190.27M
Total Assets FY 2025 · Dec 31, 2024 $202.74M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.76
Eps Diluted FY 2025 · Dec 31, 2024 −$3.83
Eps Diluted FY 2025 · Dec 31, 2023 −$5.64
Eps Basic FY 2025 · Dec 31, 2025 −$0.76
Eps Basic FY 2025 · Dec 31, 2024 −$3.83
Eps Basic FY 2025 · Dec 31, 2023 −$5.64
Sga Expense FY 2025 · Dec 31, 2025 $49.09M
Sga Expense FY 2025 · Dec 31, 2024 $55.56M
Sga Expense restated FY 2025 · Dec 31, 2023 $59.93M
Rd Expense FY 2025 · Dec 31, 2025 $25.77M
Rd Expense FY 2025 · Dec 31, 2024 $25.54M
Rd Expense restated FY 2025 · Dec 31, 2023 $21.76M
Net Income FY 2025 · Dec 31, 2025 −$10.88M
Net Income FY 2025 · Dec 31, 2024 −$56.39M
Net Income FY 2025 · Dec 31, 2023 −$82.67M
Operating Income FY 2025 · Dec 31, 2025 −$11.05M
Operating Income FY 2025 · Dec 31, 2024 −$5.1M
Operating Income restated FY 2025 · Dec 31, 2023 $844K
Gross Profit FY 2025 · Dec 31, 2025 $63.81M
Gross Profit FY 2025 · Dec 31, 2024 $76M
Gross Profit restated FY 2025 · Dec 31, 2023 $82.53M
Cost Of Revenue FY 2025 · Dec 31, 2025 $49.01M
Cost Of Revenue FY 2025 · Dec 31, 2024 $43.91M
Cost Of Revenue restated FY 2025 · Dec 31, 2023 $38.26M
Revenue FY 2025 · Dec 31, 2025 $112.82M
Revenue FY 2025 · Dec 31, 2024 $119.91M
Revenue restated FY 2025 · Dec 31, 2023 $120.79M